Q Therapeutics' Other Investors

Q Therapeutics raised a round of funding on , . Investors include Invitrogen.

Q Therapeutics, Inc. is developing glial cell-based therapeutic products for central nervous system disorders in which a disease or injury inhibits normal myelin growth and enzyme performance.…

Articles about Q Therapeutics' Other Investors: